ATYR Q2 2020 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$89M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$189,000+101.1% YoY

Gross Profit

$189,000100.0% margin

Operating Income

-$6M-3342.9% margin

Net Income

-$6M-3410.6% margin

EPS (Diluted)

$-0.69

QoQ Revenue Growth

-97.7%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$378,000

Balance Sheet

Total Assets

$48M

Total Liabilities

$12M

Stockholders' Equity

$36M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$189,000	$94,000	+101.1%
Gross Profit	$189,000	$94,000	+101.1%
Operating Income	-$6M	-$6M	-12.0%
Net Income	-$6M	-$6M	-10.2%